General Information of the Compound
Compound ID
CP0524092
Compound Name
2-[2-[4-[5-[(1-ethylpyrazol-3-yl)amino]triazolo[4,5-d]pyrimidin-1-yl]phenyl]propan-2-yloxy]ethanol
    Show/Hide
Synonyms
A-127
BDBM50011235
GTPL8169
WO2013110309CA127
    Show/Hide
Structure
Formula
C20H24N8O2
Molecular Weight
408.466
Canonical SMILES
CCn1ccc(Nc2ncc3n(nnc3n2)-c2ccc(cc2)C(C)(C)OCCO)n1
    Show/Hide
InChI
InChI=1S/C20H24N8O2/c1-4-27-10-9-17(25-27)22-19-21-13-16-18(23-19)24-26-28(16)15-7-5-14(6-8-15)20(2,3)30-12-11-29/h5-10,13,29H,4,11-12H2,1-3H3,(H,21,22,23,25)
    Show/Hide
InChIKey
XNAMZBCMLZQBIC-UHFFFAOYSA-N
Physicochemical Property
logP
2.4145
Rotatable Bonds
8
Heavy Atom Count
30
Polar Areas
115.8
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
10
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 90655897
ChEMBL ID
CHEMBL3260333
Clinical Information about the Compound
Drug 1 ( WO2013110309CA127 )
Drug Name WO2013110309CA127
Target(s)
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
Inhibitor